Yvonne Yau

Biography

Dr. Yvonne Yau received her Medical Degree from the University of Toronto in 1989.  She completed her Medical Microbiology Residency at the University of Toronto in 1994 and is currently a Medical Microbiologist at the Hospital for Sick Children. She is a Project Investigator in the Research Institute at The Hospital for Sick Children and an Assistant Professor in the Department of Pathobiology and Laboratory Medicine at the University of Toronto.  Her research interests include optimizing the diagnosis of paediatric infectious diseases, and in particular respiratory virus infections and cystic fibrosis microbiology.             Dr. Yvonne Yau received her Medical Degree from the University of Toronto in 1989.  She completed her Medical Microbiology Residency at the University of Toronto in 1994 and is currently a Medical Microbiologist at the Hospital for Sick Children. She is a Project Investigator in the Research Institute at The Hospital for Sick Children and an Assistant Professor in the Department of Pathobiology and Laboratory Medicine at the University of Toronto.  Her research interests include optimizing the diagnosis of paediatric infectious diseases, and in particular respiratory virus infections and cystic fibrosis microbiology.            

Research Interest

Dr. Yau has focused her research on the epidemiology, diagnosis and management of multi-drug resistant bacterial pahogens in cystic fibrosis (CF).  Her research involve examining the epidemiology and clinical significance of Stenotrophomonas maltophilia infections in pediatric and adult CF patients, as well as determining the most effect antimicrobial combinations for the treatment of this infection in CF.   She was the co-principal investigator on a multi-center randomnized controlled trial evaluating the utility of biofilm susceptibility assay in choosing more effective antibiotics to treat CF patients with chronic Pseudomonas aeruginosa pulmonary infection.   She is also investigating the use of novel antimicrobial agents/modalities in the treatment of CF patients with multi-drug resistant Gram negative bacterial pulmonary infections.  In addition, Dr. Yau is involved in a national multicentre study to determine the role of transmissible, clonal P. aeruginosa in the Canadian CF patient population and part of a CIHR-funded Canadian Microbiome initiative characterizing the polymicrobial communities in the CF lung.